• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    NeueHealth Acquires Full Ownership of Centrum Health

    10/30/24 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care
    Get the next $NEUE alert in real time by email

    NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company's value-driven clinic brands, became a wholly owned subsidiary through the Company's acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth's corporate structure, streamlining operations to support its ongoing focus on advancing its value-driven, consumer-centric care model.

    "We are pleased to announce this transaction as it further positions NeueHealth to take the lead in creating a more coordinated, seamless healthcare experience for all consumers," said Mike Mikan, President and CEO of NeueHealth. "We look forward to continuing to drive value in healthcare for all as we look to build on our success in 2025 and beyond."

    More information regarding the key terms will be included in a Form 8-K to be filed by NeueHealth with the Securities and Exchange Commission.

    About NeueHealth

    NeueHealth is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. NeueHealth delivers high-quality clinical care to over 500,000 health consumers through owned clinics and unique partnerships with over 3,000 affiliated providers. We also enable independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally. We believe our value-driven, consumer-centric care model can transform the healthcare experience and maximize value across the healthcare system. For more information, visit: www.neuehealth.com.

    Forward-Looking Statements

    Statements made in this release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as "anticipate," "expect," "plan," "believe," "intend," "project," "forecast," "estimates," "projections," "outlook," "ensure," and other similar expressions. These forward-looking statements include any statements regarding our plans, expectations and financial guidance. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Factors that might materially affect such forward-looking statements include: our ability to continue as a going concern; our ability to comply with the terms of our credit facilities­ or any credit facility into which we enter in the future; our ability to receive the remaining proceeds from the sale of our Medicare Advantage business in California in a timely manner; our ability to obtain any short or long term debt or equity financing needed to operate our business; our ability to quickly and efficiently complete the wind down of our remaining Individual and Family Plan ("IFP") and MA businesses, including by satisfying liabilities of those businesses when due and payable; potential disruptions to our business due to corporate restructuring and any resulting headcount reduction; our ability to accurately estimate and effectively manage the costs relating to changes in our business offerings and models; a delay or inability to withdraw regulated capital from our subsidiaries; a lack of acceptance or slow adoption of our business model; our ability to retain existing consumers and expand consumer enrollment; our and our care partner's abilities to obtain and accurately assess, code, and report risk adjustment factor scores; our ability to contract with care providers and arrange for the provision of quality care; our ability to obtain claims information timely and accurately; the impact of any pandemic or epidemic on our business and results of operations; the risks associated with our reliance on third-party providers to operate our business; the impact of modifications or changes to the U.S. health insurance markets; our ability to manage any growth of our business; our ability to operate, update or implement our technology platform and other information technology systems; our ability to retain key executives; our ability to successfully pursue acquisitions, integrate acquired businesses, and quickly and efficiently divest businesses as needed; the occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest; our ability to prevent and contain data security incidents and the impact of data security incidents on our members, patients, employees and financial results; our ability to comply with requirements to maintain effective internal controls; our ability to adapt to mitigate risks associated with our ACO businesses, including any unanticipated market or regulatory developments; and the other factors set forth under the heading "Risk Factors" in the Company's reports on Form 10-K, Form 10-Q, and Form 8-K (including all amendments to those reports) and our other filings with the SEC. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or changes in our expectations.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241030110559/en/

    Get the next $NEUE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What recent acquisition did NeueHealth announce?

      NeueHealth acquired the remaining 25% equity interest in Centrum Health, making it a wholly owned subsidiary.

    • How does the acquisition of Centrum Health benefit NeueHealth's operations?

      The acquisition simplifies the corporate structure of NeueHealth and supports its focus on value-driven, consumer-centric care.

    • What did the CEO of NeueHealth say about the significance of this acquisition?

      Mike Mikan, the President and CEO, expressed that the acquisition positions NeueHealth to lead in creating a more coordinated healthcare experience for consumers.

    • Where can we find more information on the acquisition details?

      The Form 8-K will contain more details regarding the key terms of the acquisition, which must be filed with the SEC.

    • What is the business model of NeueHealth, and how does it aim to impact healthcare?

      NeueHealth aims to provide high-quality, coordinated care and has a consumer-centric model that they believe can transform healthcare.

    Recent Analyst Ratings for
    $NEUE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEUE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Scherman Jeffrey J converted options into 341 shares, increasing direct ownership by 3% to 12,575 units (SEC Form 4)

      4 - NeueHealth, Inc. (0001671284) (Issuer)

      5/13/25 6:06:42 PM ET
      $NEUE
      Medical Specialities
      Health Care
    • Chief Financial Officer Matushak Jay converted options into 978 shares, increasing direct ownership by 2% to 41,028 units (SEC Form 4)

      4 - NeueHealth, Inc. (0001671284) (Issuer)

      5/13/25 6:06:05 PM ET
      $NEUE
      Medical Specialities
      Health Care
    • Chief Accounting Officer Scherman Jeffrey J sold $9,039 worth of shares (1,373 units at $6.58), decreasing direct ownership by 10% to 12,234 units (SEC Form 4)

      4 - NeueHealth, Inc. (0001671284) (Issuer)

      3/17/25 8:40:45 PM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    Financials

    Live finance-specific insights

    See more
    • NeueHealth Reports First Quarter 2025 Results

      Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

      5/8/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025

      NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participant

      4/23/25 8:00:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Reports Fourth Quarter and Full Year 2024 Results

      Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our

      3/20/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NeueHealth Reports First Quarter 2025 Results

      Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

      5/8/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025

      NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participant

      4/23/25 8:00:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Reports Fourth Quarter and Full Year 2024 Results

      Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our

      3/20/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by NeueHealth Inc. (Amendment)

      SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

      4/10/24 9:52:09 PM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    SEC Filings

    See more
    • SEC Form 10-Q filed by NeueHealth Inc.

      10-Q - NeueHealth, Inc. (0001671284) (Filer)

      5/9/25 6:34:33 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - NeueHealth, Inc. (0001671284) (Filer)

      5/8/25 5:11:35 PM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - NeueHealth, Inc. (0001671284) (Filer)

      5/8/25 6:46:30 AM ET
      $NEUE
      Medical Specialities
      Health Care